Understanding how certain proteins are inserted into the outer membrane of mitochondria
Biogenesis of alpha-helical mitochondrial outer membrane proteins in higher eukaryotes
This study is looking at how a special protein called MTCH2 helps other proteins get into the outer part of our cell's energy factories, the mitochondria, which is important for keeping our cells healthy and could help us understand diseases like Alzheimer's better.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | California Institute of Technology NIH-funded |
| Lab location | 1 site (Pasadena, United States) |
| Project ID | NIH-10891727 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which alpha-helical proteins are inserted into the outer mitochondrial membrane (OMM) in mammalian cells. It focuses on a specific protein, MTCH2, which has been identified as crucial for this process. By utilizing bioinformatics and biochemical techniques, the research aims to uncover the targeting and insertion pathways of these proteins, which are vital for cellular functions such as apoptosis and immune response. Patients may benefit from insights gained into mitochondrial function and its implications for diseases like Alzheimer's.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related dementias.
Not a fit: Patients with non-neurological conditions or those not affected by mitochondrial dysfunction may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating Alzheimer's disease and other conditions linked to mitochondrial dysfunction.
How similar studies have performed: Previous research has shown promising results in understanding mitochondrial protein insertion, suggesting that this approach could yield valuable insights.
Where this research is happening
Pasadena, United States
- California Institute of Technology — Pasadena, United States (Active)
Researchers
- Principal investigator: Guna, Alina-Ioana — California Institute of Technology
- Study coordinator: Guna, Alina-Ioana
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.